Cardiac Biomarkers Market to surpass USD 17.55 Billion by 2028
According to the current analysis of Reports and Data, the global Cardiac Biomarkers market was valued at USD 7.96 Billion in 2020 and is expected to reach USD 17.55 Billion by year 2028, at a CAGR of 10.4%. According to the Centre for Disease Control and Prevention (CDC), for around 610,000 people die of heart disease in United States every year, that’s 1 in every 4 deaths and more than half of the deaths due to heart disease were in men. Cardiac biomarkers are protein-based observable materials discharged into blood when the heart’s muscles are wounded which can be used as risk stratification for numerous cardiovascular diseases (CVDs) that includes Acute Myocardial Infarction (AMI), Ischemia, Congestive Heart Failure (CHF), Acute Coronary Syndrome (ACS) and others related with insufficient blood flow to heart. The high occurrence rates of CVDs worldwide and the growing demand for POC cardiac testing kits are expected to fuel the market growth. Certain manufactu...